pindolol has been researched along with Endomyocardial Fibrosis in 1 studies
Pindolol: A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638)
pindolol : A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol.
Endomyocardial Fibrosis: A condition characterized by the thickening of the ventricular ENDOCARDIUM and subendocardium (MYOCARDIUM), seen mostly in children and young adults in the TROPICAL CLIMATE. The fibrous tissue extends from the apex toward and often involves the HEART VALVES causing restrictive blood flow into the respective ventricles (CARDIOMYOPATHY, RESTRICTIVE).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yamashita, K | 1 |
| Shigematsu, K | 1 |
| Maeda, T | 1 |
| Ishida, Y | 1 |
| Niwa, M | 1 |
| Ozaki, M | 1 |
1 other study available for pindolol and Endomyocardial Fibrosis
| Article | Year |
|---|---|
[Antihypertensive effect of bopindolol on stroke-prone spontaneously hypertensive rats (SHRSP)].
Topics: Administration, Oral; Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Blood Pressure; | 1989 |